Heterogeneous neurocognitive signatures in early childhood autism: a combined analysis of pharmacological treatment and gender
CONCLUSIONS: Pharmacological treatment type and gender are important factors associated with heterogeneity in neurocognitive profiles in early childhood (4-6 years) ASD. These findings suggest that medication-related differences extend beyond behavioral…
Suggested reading